Vaccine Tracking Data—The Next Big Alt Dataset
Investment firms and vendors are searching for signals in healthcare and pharmaceutical data in a bid to get a leg up on a Covid-19 vaccine.
One year ago, no one foresaw the coronavirus pandemic and the havoc it would wreak on every aspect of life and work. As fear and anxiety have spread across the globe, it’s becoming increasingly clear that the only way back to “normal” is the development of a drug that combats the Covid-19 virus.
While ordinary people anxiously await a vaccine, the market is transfixed by the idea of a treatment for this highly contagious disease. Investors are keen to bet on which companies will be successful
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Data Management
Waters Wavelength Ep. 303: AggKnowledge’s Dan Entrup
Dan, who also created the It’s Pronounced Data newsletter, joins the show to discuss the growing interest in private markets data, artificial intelligence, and more.
Cusip Global Services wants to know, ‘What’s your damage?’
The evidence and discovery phase of the case against the identifier bureau is set to expire in March, bringing an anticipated jury trial one step closer.
‘We started late’: Oracle makes case for its market data cloud offering
Executives from Oracle, LSEG, and CJC detailed the ‘eye-opening’ performance and latency of the Oracle Cloud Infrastructure.
From frozen assets to fire sales: The datasets to prevent your investments going up in smoke
The IMD Wrap: As severe weather conditions become more commonplace, Max wonders which datasets will prove most useful for those navigating a changing world.
Opra considers ‘dynamic load balancing’ for options market
The data distributor recently completed a challenging project to build a 96-line feed. This new endeavor could prove just as challenging (but perhaps necessary) for the industry that will use it.
Market data for private markets? BlackRock sees its big opportunity
The investment giant’s CEO said he envisions a far bigger private market business in 2025.
Bloomberg debuts GenAI news summaries
The AI-generated summaries will allow financial professionals to consume more data, faster, officials say.
Substantive Research reveals new metrics for market data negotiations framework
The research firm will make its industry-derived project available for public consumption next month.
